Skip To Content

Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF)

Started Jan 18, 2022

$15 Enroll

Full course description

Target Audience: Pharmacists in all practice settings

Type of Activity: This is a knowledge-based activity

Fees: non-PAWNY members: $15.00, PAWNY members: $10.00*

*PAWNY members use promo code "PAWNY2022" for discounted fee.

Learning Objectives:

  1. 1.    Review the historical management of heart failure with preserved ejection fraction (HFpEF)
  2. 2.    Describe the study design, methods and patient population studied in the EMPEROR-Preserved trial
  3. 3.    Summarize the significant findings of the EMPEROR-Preserved trial
  4. 4.    Translate the results of the EMPEROR-Preserved trial to a HFpEF patient case

Continuing Education Information: D’Youville College School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE #: 0645-9999-22-002-H01-P and will award 0.5 contact hours (0.05 CEU) of continuing pharmacy education credit. Credit will be uploaded to CPE Monitor to attendees who complete the CE post-test and evaluation form.